• New Vaccine

    Posted by makinfo on May 25, 2023

    The trial with the new pentavalent vaccine NmCV-5 found no safety concerns with NmCV-5. It induces a strong immune response across five strains of meningococcal bacteria: A, C,…


    Continue reading